EVOKE PHARMA INC's ticker is and the CUSIP is 30049G203. A total of 13 filers reported holding EVOKE PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 2,248 | $4,000 | 0.00% |
| VANGUARD GROUP INC | 29,851 | $56,000 | 0.00% |
| UBS Group AG | 1,107 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 16 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 338 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,894 | $39,000 | 0.00% |
| MORGAN STANLEY | 1 | $0 | 0.00% |
| BlackRock Inc. | 7,977 | $15,000 | 0.00% |
| HARBOR INVESTMENT ADVISORY, LLC | 83 | $0 | 0.00% |